Artiva Biotherapeutics (ARTV) Total Liabilities (2023 - 2025)
Historic Total Liabilities for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $19.6 million.
- Artiva Biotherapeutics' Total Liabilities fell 2017.07% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year decrease of 2017.07%. This contributed to the annual value of $22.9 million for FY2024, which is 5476.77% down from last year.
- Artiva Biotherapeutics' Total Liabilities amounted to $19.6 million in Q3 2025, which was down 2017.07% from $20.3 million recorded in Q2 2025.
- Artiva Biotherapeutics' Total Liabilities' 5-year high stood at $174.7 million during Q1 2024, with a 5-year trough of $19.6 million in Q3 2025.
- In the last 3 years, Artiva Biotherapeutics' Total Liabilities had a median value of $37.6 million in 2024 and averaged $70.2 million.
- The largest annual percentage gain for Artiva Biotherapeutics' Total Liabilities in the last 5 years was 2017.07% (2025), contrasted with its biggest fall of 8713.02% (2025).
- Quarter analysis of 3 years shows Artiva Biotherapeutics' Total Liabilities stood at $50.7 million in 2023, then plummeted by 54.77% to $22.9 million in 2024, then decreased by 14.39% to $19.6 million in 2025.
- Its last three reported values are $19.6 million in Q3 2025, $20.3 million for Q2 2025, and $22.5 million during Q1 2025.